← Leaderboards
Laura L Dugan
Veterans Health Administration
$6,075,631
Attributed
$6,075,631
Total exposure
11
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $445.4K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,075,631 · 10
VA$0 · 1
By mechanism
R01$5,571,140 · 4
R21$468,753 · 1
P41$35,738 · 5
I01$0 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposReportingSignal TransductionS DiseaseAgingSuperoxidesInflammationMouse ModelInterleukin-6AstrocytesChronicBrainInflammatoryEtiologyNadph OxidaseAgedAge RelatedModificationMediatingProductionCellsDesignIn VivoAnimals
Grant awards (32)
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.$0
I01 · FY2023 · VA · contact PI
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain$359,879
R01 · FY2022 · AG · contact PI
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.$0
I01 · FY2022 · VA · contact PI
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain$359,879
R01 · FY2021 · AG · contact PI
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.$0
I01 · FY2021 · VA · contact PI
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain$405,093
R01 · FY2020 · AG · contact PI
Novel treatments for neuropsychiatric symptoms in Alzheimers Disease (AD): targeting inflammatory injury using three translational anti-inflammatory strategies in a new AD model.$0
I01 · FY2020 · VA · contact PI
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain$406,685
R01 · FY2019 · AG · contact PI
Inflammatory Mechanisms Underlie Lysosome Failure in the Aging Brain$445,432
R01 · FY2018 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$290,613
R01 · FY2014 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$18,749
R01 · FY2014 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$288,622
R01 · FY2013 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$99,215
R01 · FY2013 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$305,421
R01 · FY2012 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$304,436
R01 · FY2011 · AG · contact PI
Systemic Inflammation and Central Nervous System Dysfunction$316,725
R01 · FY2010 · AG · contact PI
Improved Spin Probes for Magnetic Resonance Imaging of Oxygen and Reactive Oxygen$155,195
R21 · FY2009 · AG · contact PI
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$115
P41 · FY2009 · RR · contact PI
Improved Spin Probes for Magnetic Resonance Imaging of Oxygen and Reactive Oxygen$155,195
R21 · FY2008 · AG · contact PI
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$660
P41 · FY2008 · RR · contact PI
Improved Spin Probes for Magnetic Resonance Imaging of Oxygen and Reactive Oxygen$158,363
R21 · FY2007 · AG · contact PI
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$1,582
P41 · FY2007 · RR · contact PI
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$5,072
P41 · FY2006 · RR · contact PI
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$3,390
P41 · FY2005 · RR
UCP5-- Balancing Metabolism and Oxidation in Aging Brain$274,120
R01 · FY2004 · NS
UCP5-- Balancing Metabolism and Oxidation in Aging Brain$72,380
R01 · FY2004 · NS
CHARACTERIZATION OF NEUROPROTECTIVE CARBOXYFULLERENES$24,919
P41 · FY2004 · RR
UCP5-- Balancing Metabolism and Oxidation in Aging Brain$346,500
R01 · FY2003 · NS
UCP5-- Balancing Metabolism and Oxidation in Aging Brain$346,500
R01 · FY2002 · NS
UCP5-- Balancing Metabolism and Oxidation in Aging Brain$346,594
R01 · FY2001 · NS
MECHANISMS OF NEUROPROTECTION BY C60 DERIVATIVES$296,466
R01 · FY2001 · NS
MECHANISMS OF NEUROPROTECTION BY C60 DERIVATIVES$287,831
R01 · FY2000 · NS